AUROBINDO PHARMA LTD FDA Approval ANDA 210479

ANDA 210479

AUROBINDO PHARMA LTD

FDA Drug Application

Application #210479

Application Sponsors

ANDA 210479AUROBINDO PHARMA LTD

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL1MG/ML0ARIPIPRAZOLEARIPIPRAZOLE

FDA Submissions

UNKNOWN; ORIG1AP2019-01-29STANDARD
LABELING; LabelingSUPPL2AP2020-02-04STANDARD
LABELING; LabelingSUPPL4AP2020-02-05STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null15
SUPPL4Null15

TE Codes

001PrescriptionAA

CDER Filings

AUROBINDO PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210479
            [companyName] => AUROBINDO PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"ARIPIPRAZOLE","activeIngredients":"ARIPIPRAZOLE","strength":"1MG\/ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/29\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"02\/05\/2020","submission":"SUPPL-4","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"02\/04\/2020","submission":"SUPPL-2","supplementCategories":"Labeling-Medication Guide, Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-02-05
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.